Acurx Pharmaceuticals Inc (NASDAQ:ACXP) has a beta value of -1.68 and has seen 0.48 million shares traded in the recent trading session. The company, currently valued at $14.12M, closed the recent trade at $0.84 per share which meant it lost -$0.25 on the day or -23.30% during that session. The ACXP stock price is -528.57% off its 52-week high price of $5.28 and 14.29% above the 52-week low of $0.72. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.21 million shares traded. The 3-month trading volume is 151.74K shares.
Acurx Pharmaceuticals Inc (NASDAQ:ACXP) trade information
Sporting -23.30% in the red today, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the ACXP stock price touched $0.84 or saw a rise of 32.8%. Year-to-date, Acurx Pharmaceuticals Inc shares have moved 2.70%, while the 5-day performance has seen it change -1.99%. Over the past 30 days, the shares of Acurx Pharmaceuticals Inc (NASDAQ:ACXP) have changed 8.25%. Short interest in the company has seen 0.47 million shares shorted with days to cover at 12.59.
Acurx Pharmaceuticals Inc (ACXP) estimates and forecasts
Figures show that Acurx Pharmaceuticals Inc shares have outperformed across the wider relevant industry. The company’s shares have lost -60.75% over the past 6 months, with this year growth rate of 22.61%, compared to 16.90% for the industry. Revenue growth from the last financial year stood is estimated to be 0.00%.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -17.77% over the past 5 years.
ACXP Dividends
Acurx Pharmaceuticals Inc is expected to release its next earnings report in February this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Acurx Pharmaceuticals Inc (NASDAQ:ACXP)’s Major holders
Insiders own 14.80% of the company shares, while shares held by institutions stand at 11.96% with a share float percentage of 14.04%. Investors are also buoyed by the number of investors in a company, with Acurx Pharmaceuticals Inc having a total of 28.0 institutions that hold shares in the company. The top two institutional holders are VANGUARD GROUP INC with over 0.49 million shares worth more than $1.11 million. As of 2024-06-30, VANGUARD GROUP INC held 3.1778% of shares outstanding.
The other major institutional holder is PROSPECT FINANCIAL SERVICES LLC, with the holding of over 0.28 million shares as of 2024-06-30. The firm’s total holdings are worth over $0.63 million and represent 1.7974% of shares outstanding.
